Purchase of 104,166 shares at $9.60 per share.
Reporting Person Cherry Brian N · Transaction Code P
Traded Sep 4, 2026 · Disclosed Sep 4, 2026
Source: SEC Form 4 · 0000905148-26-004085 · filed 2026-09-04 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Atara Biotherapeutics, Inc. (ATRA)." Disclosed 2026-09-04. https://desqlong.com/cards/0000905148-26-004085-1 (retrieved 2026-09-26).